P, G., JM, G., A, L., S, Y., A, G., JJ, G., . . . P, T. (2025). Prevalence of transthyretin cardiac amyloidosis in patients with heart failure with preserved ejection fraction: The PRACTICA study.
Citación estilo ChicagoP, García-Pavía, et al. Prevalence of Transthyretin Cardiac Amyloidosis in Patients With Heart Failure With Preserved Ejection Fraction: The PRACTICA Study. 2025.
Cita MLAP, García-Pavía, et al. Prevalence of Transthyretin Cardiac Amyloidosis in Patients With Heart Failure With Preserved Ejection Fraction: The PRACTICA Study. 2025.
Precaución: Estas citas no son 100% exactas.